Enovis Overview

  • Founded
  • 1995

Founded
  • Status
  • Public

  • Employees
  • 6,800

Employees
  • Stock Symbol
  • ENOV

Stock Symbol
  • Investments
  • 36

  • Share Price
  • $51.42

  • (As of Monday Closing)

Enovis General Information

Description

Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.. The company conducts its operations through two operating segments: Prevention & Recovery ("P&R") and Reconstructive ("Recon"). It generates majority revenue form Prevention & Recovery segment.

Contact Information

Website
www.enovis.com
Formerly Known As
Colfax
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Machinery (B2B)
Stock Exchange
NYS
Primary Office
  • 2711 Centerville Road
  • Suite 400
  • Wilmington, DE 19808
  • United States
+1 (302) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enovis Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$51.42 $51.58 $43.88 - $72.13 $2.8B 54.3M 340K -$0.25

Enovis Financials Summary

In Thousands,
USD
TTM 31-Dec-2022 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 3,169,473 3,169,473 8,770,968 6,897,661
Revenue 1,563,101 1,563,101 1,426,188 1,120,700
EBITDA 241,693 241,693 170,250 180,047
Net Income (13,292) (13,292) 71,657 42,625
Total Assets 4,273,248 4,273,248 8,515,912 7,351,549
Total Debt 334,819 334,819 2,164,811 2,410,168
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Enovis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enovis‘s full profile, request access.

Request a free trial

Enovis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate meas
Machinery (B2B)
Wilmington, DE
6,800 As of 2022
00.000
000000 - 000 00.000

000000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolo
000000000 (000)
Davenport, IA
000 As of 0000
0000 0000-00-00
000000&0

000000

liquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt
000000000 (000)
Hanover, NH
0000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enovis Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genesis Systems Group Corporate Backed or Acquired Davenport, IA 000 000000&0
0000000000 0000000 Venture Capital-Backed Hanover, NH 0000 00.000 000000000 00.000
00000 Corporation Cleveland, OH 00000 00000000
000 0000000 000000 Corporation Cleveland, OH 00000 00000000
00000 Formerly VC-backed Downers Grove, IL 00000 00000000
You’re viewing 5 of 15 competitors. Get the full list »

Enovis Patents

Enovis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220379399-A1 Connector assembly for arc process components Pending 27-May-2021 00000000
US-20220324049-A1 Overvoltage protection for current braking switch Pending 13-Apr-2021 000000000
US-20220274198-A1 Braking energy recovery circuit Pending 01-Mar-2021 0000000000
US-20220023965-A1 Balance and offset in adaptive submerged arc welding Pending 21-Jul-2020 0000000000
EP-4121245-A1 Electroslag strip cladding Pending 17-Mar-2020 E01B5/08
To view Enovis’s complete patent history, request access »

Enovis Executive Team (32)

Name Title Board Seat Contact Info
Matthew Trerotola Chief Executive Officer & Board Member
Andrew Fox-Smith President of International Business
Christopher Hix Chief Financial Officer, Finance & Executive Vice President
Patricia Lang Executive & Senior Vice President
Daniel Pryor Executive Vice President
You’re viewing 5 of 32 executive team members. Get the full list »

Enovis Board Members (21)

Name Representing Role Since
0. 0000000 Enovis Board Member 000 0000
000000 00000 Enovis Board Member 000 0000
0000000 00000 Self Board Member 000 0000
00000 0000000 Self Chief Operating Officer, Operations & Board Member 000 0000
000000000 00000 Enovis Board Member 000 0000
You’re viewing 5 of 21 board members. Get the full list »

Enovis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enovis Investments & Acquisitions (36)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 05-Jul-2022 0000000000 Surgical Devices 0000000 0
000 000 0000 06-May-2022 0000000000 Surgical Devices 000000 00
0000000 00000 19-Mar-2021 0000 00000 000 Surgical Devices
0000000 (0000 13-Nov-2020 000000000 0000 Buildings and Property 0000000 0
DJO Global 25-Feb-2019 Merger/Acquisition 00.000 Therapeutic Devices 0000000 0
You’re viewing 5 of 36 investments and acquisitions. Get the full list »

Enovis Subsidiaries (12)

Company Name Industry Location Founded
Insight Medical Systems Surgical Devices Austin, TX 2016
000 000 0000 Surgical Devices Pymble, Australia 0000
000000 (0000000000 Industrial Supplies and Parts Lima, Peru 0000
000000000 00000000 Other Commercial Products West Conshohocken, PA 0000
000 00000000000000 Industrial Supplies and Parts Halle, Germany 0000
You’re viewing 5 of 12 subsidiaries. Get the full list »

Enovis ESG

Risk Overview

Risk Rating

Updated November, 29, 2022

34.07 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,231

Rank

00.00

Percentile

Machinery

Industry

00 of 546

Rank

00.00

Percentile

Industrial Machinery

Subindustry

00 of 404

Rank

00.0

Percentile

To view Enovis’s complete esg history, request access »

Enovis Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000 00000 09-Jul-2013 000000000000000000 000.00 Completed
  • 000000
To view Enovis’s complete exits history, request access »